Loading organizations...
Ming Capital operates as a global healthcare venture capital firm, primarily based in Shenzhen, China. The firm deploys capital into innovative companies within the healthcare sector, focusing on identifying and nurturing emerging technologies and solutions. Their investment strategy targets the evolving landscape of global health, providing crucial funding and strategic guidance to portfolio companies navigating complex market dynamics.
The company was founded in 2015 by Huang Xiaoming and Zhang Xiaoting. Their establishment of Ming Capital was driven by a clear recognition of the significant opportunities and growing needs within the global healthcare industry, particularly within the dynamic Chinese market. This initiative aimed to bridge the gap between groundbreaking medical advancements and the necessary financial backing for their development and market entry.
Ming Capital serves early to growth-stage companies and entrepreneurs dedicated to advancing healthcare. The firm's overarching vision is to contribute to the progression of global health by empowering disruptive innovations and supporting the next generation of healthcare leaders. They aspire to foster a robust ecosystem where promising healthcare ventures can thrive and make a lasting impact.
Key people at Ming Capital.
Ming Capital has 1 tracked investment across 1 company. The latest tracked deal is $34.8M Series D in Miracor Medical SA in September 2018.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 4, 2018 | Miracor Medical SA | $34.8M Series D | Ming Capital | Noshaq, Quest For Growth, Sfpi |
Key people at Ming Capital.